160 related articles for article (PubMed ID: 1382595)
21. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
[TBL] [Abstract][Full Text] [Related]
22. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Luttrell DK; Lee A; Lansing TJ; Crosby RM; Jung KD; Willard D; Luther M; Rodriguez M; Berman J; Gilmer TM
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):83-7. PubMed ID: 7506422
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
[TBL] [Abstract][Full Text] [Related]
24. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
[TBL] [Abstract][Full Text] [Related]
25. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
Garcia P; Shoelson SE; Drew JS; Miller WT
J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
[TBL] [Abstract][Full Text] [Related]
26. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding.
Williams KP; Shoelson SE
Biochemistry; 1993 Oct; 32(42):11279-84. PubMed ID: 7692962
[TBL] [Abstract][Full Text] [Related]
27. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
Weber T; Schaffhausen B; Liu Y; Günther UL
Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912
[TBL] [Abstract][Full Text] [Related]
28. Examination of the dephosphorylation reactions catalyzed by pp60c-src tyrosine kinase explores the roles of autophosphorylation and SH2 ligand binding.
Boerner RJ; Kassel DB; Edison AM; Knight WB
Biochemistry; 1995 Nov; 34(45):14852-60. PubMed ID: 7578095
[TBL] [Abstract][Full Text] [Related]
29. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
30. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
Rordorf-Nikolic T; Van Horn DJ; Chen D; White MF; Backer JM
J Biol Chem; 1995 Feb; 270(8):3662-6. PubMed ID: 7876105
[TBL] [Abstract][Full Text] [Related]
31. Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts.
Bachelot C; Rameh L; Parsons T; Cantley LC
Biochim Biophys Acta; 1996 Mar; 1311(1):45-52. PubMed ID: 8603102
[TBL] [Abstract][Full Text] [Related]
32. Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains.
Herbst JJ; Andrews G; Contillo L; Lamphere L; Gardner J; Lienhard GE; Gibbs EM
Biochemistry; 1994 Aug; 33(32):9376-81. PubMed ID: 7520748
[TBL] [Abstract][Full Text] [Related]
33. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
[TBL] [Abstract][Full Text] [Related]
34. pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.
Brewster CE; Glover HR; Dilworth SM
J Virol; 1997 Jul; 71(7):5512-20. PubMed ID: 9188625
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.
Nolte RT; Eck MJ; Schlessinger J; Shoelson SE; Harrison SC
Nat Struct Biol; 1996 Apr; 3(4):364-74. PubMed ID: 8599763
[TBL] [Abstract][Full Text] [Related]
36. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells.
Ling LE; Druker BJ; Cantley LC; Roberts TM
J Virol; 1992 Mar; 66(3):1702-8. PubMed ID: 1371171
[TBL] [Abstract][Full Text] [Related]
37. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
[TBL] [Abstract][Full Text] [Related]
38. Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A.
Campbell KS; Auger KR; Hemmings BA; Roberts TM; Pallas DC
J Virol; 1995 Jun; 69(6):3721-8. PubMed ID: 7538174
[TBL] [Abstract][Full Text] [Related]
39. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
40. Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
Brümmer J; Neumaier M; Göpfert C; Wagener C
Oncogene; 1995 Oct; 11(8):1649-55. PubMed ID: 7478590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
